Merck KGaA (OTCMKTS:MKKGY) Sets New 12-Month Low – Here’s Why

Merck KGaA (OTCMKTS:MKKGY) reached a new 52-week low on Wednesday . The stock traded as low as $27.19 and last traded at $27.23, with a volume of 47833 shares trading hands. The stock had previously closed at $28.26.

Merck KGaA Trading Up 1.7 %

The firm has a market cap of $18.24 billion, a P/E ratio of 17.43, a P/E/G ratio of 2.05 and a beta of 0.98. The stock has a 50 day simple moving average of $29.15 and a 200-day simple moving average of $31.05. The company has a current ratio of 1.33, a quick ratio of 0.91 and a debt-to-equity ratio of 0.28.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings results on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.07. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. The company had revenue of $5.78 billion for the quarter, compared to analysts’ expectations of $5.40 billion. On average, equities research analysts expect that Merck KGaA will post 1.87 EPS for the current fiscal year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.